Webinar on models for drug development programmes by Charles River:

The emergence of antibiotic-resistant bacteria and genetic variance amongst viruses has embattled the development of effective treatment and vaccination against infectious diseases, leading to a worldwide crisis in medical care.
This webinar will help you choose the correct models for your drug development program; from early in vitro screening assays providing identification of efficacy, to a range of clinically relevant in vivo models. We also explore the use of the Galleria mellonella (wax moth larvae) model as an additional early proof-of-concept model prior to in vivo testing, which provides essential information on toxicity and dosing regimens, ensuring optimum assessment of compounds particularly in the use of combination therapies.

Presenter: Claire Richards, PhD, Principal Scientist, Infectious Disease, Discovery Services, Charles River

To watch the recording, please visit the Charles River website.